CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Nov 14, 2014
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options(Right to Buy)
2014-04-03+100,000→ 100,000 totalExercise: $1.84Exp: 2024-04-03→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options vested as a result of the reported license transaction with Spectrum Pharmaceuticals, Inc. on September 17, 2014.